NCT00967785
- Conditions
- Agammaglobulinemia, Agranulocytosis, Blood Protein Disorders, +21 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Explore clinical trials studying Myelokathexis. Study availability and eligibility vary by location and protocol.
NCT00967785
NCT02231879